Insulin therapy and in-hospital mortality in critically ill patients: systematic review and meta-analysis of randomized controlled trials.
暂无分享,去创建一个
[1] I. Hjermann. A controlled study of peroral glucose, insulin and potassium treatment in myocardial infarction. , 2009, Acta medica Scandinavica.
[2] E. Ikkala,et al. Anticoagulants and Sodi-Pallares infusion in acute myocardial infarction. , 2009, Acta medica Scandinavica.
[3] T. Lundman,et al. Insulin-glucose-potassium infusion in acute myocardial infarction. , 2009, Acta medica Scandinavica.
[4] M. Laakso,et al. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity , 2005 .
[5] Jun Zhu,et al. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial. , 2005, JAMA.
[6] J. Lau,et al. Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials. , 2004, Archives of internal medicine.
[7] John Hoey,et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2004, JAMA.
[8] S. Nekolla,et al. A randomized evaluation of the effects of glucose-insulin-potassium infusion on myocardial salvage in patients with acute myocardial infarction treated with reperfusion therapy. , 2004, American heart journal.
[9] Neil J Grey,et al. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[10] Howard Cabral,et al. Tight Glycemic Control in Diabetic Coronary Artery Bypass Graft Patients Improves Perioperative Outcomes and Decreases Recurrent Ischemic Events , 2004, Circulation.
[11] Felix Zijlstra,et al. Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. , 2003, Journal of the American College of Cardiology.
[12] G. Grunkemeier,et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. , 2003, The Journal of thoracic and cardiovascular surgery.
[13] M. Demircin,et al. Perioperative hyperglycemia is a strong correlate of postoperative infection in type II diabetic patients after coronary artery bypass grafting. , 2002, Endocrine journal.
[14] J. Hammon,et al. Intraoperative insulin therapy does not reduce the need for inotropic or antiarrhythmic therapy after cardiopulmonary bypass. , 2002, Journal of cardiothoracic and vascular anesthesia.
[15] B. Riedel,et al. Coronary revascularization: a procedure in transition from on-pump to off-pump? The role of glucose-insulin-potassium revisited in a randomized, placebo-controlled study. , 2002, Journal of cardiothoracic and vascular anesthesia.
[16] A. Hamsten,et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study , 2002, The Lancet.
[17] Ethan M Balk,et al. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomized controlled trials. , 2002, JAMA.
[18] M. Borger,et al. The insulin cardioplegia trial: myocardial protection for urgent coronary artery bypass grafting. , 2002, The Journal of thoracic and cardiovascular surgery.
[19] D. McGiffin,et al. Glucose-insulin-potassium infusion for myocardial protection during off-pump coronary artery surgery. , 2002, The Annals of thoracic surgery.
[20] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[21] M. S. Ulgen,et al. The effect of glucose–insulin–potassium solution on ventricular late potentials and heart rate variability in acute myocardial infarction , 2001, Coronary artery disease.
[22] L. Jorfeldt,et al. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes. , 2001, Clinical science.
[23] J. Cornel,et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. , 2001, International journal of cardiology.
[24] R. Toomath,et al. Follow up testing of hyperglycaemia during hospital admission: combined use of fasting plasma glucose and HbA1c. , 2000, The New Zealand medical journal.
[25] S. Chipkin,et al. Glucose-insulin-potassium solutions improve outcomes in diabetics who have coronary artery operations. , 2000, The Annals of thoracic surgery.
[26] J. L. Tang,et al. Misleading funnel plot for detection of bias in meta-analysis. , 2000, Journal of clinical epidemiology.
[27] H. Gerstein,et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview , 2000, The Lancet.
[28] P. Lee,et al. Publication bias in meta-analysis: its causes and consequences. , 2000, Journal of clinical epidemiology.
[29] S. Işıksoy,et al. Clinical, biochemical and histochemical assessment of pretreatment with glucose-insulin-potassium for patients undergoing mitral valve replacement in the third and fourth functional groups of the New York Heart Association. , 1999, Cardiovascular surgery.
[30] M. Egger,et al. The hazards of scoring the quality of clinical trials for meta-analysis. , 1999, JAMA.
[31] K. Kawecka-Jaszcz,et al. Low-Dose Glucose-Insulin-Potassium Is Ineffective in Acute Myocardial Infarction: Results of a Randomized Multicenter Pol-GIK Trial , 1999, Cardiovascular Drugs and Therapy.
[32] K. Alberti,et al. Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). , 1999, Stroke.
[33] L. Piegas,et al. Metabolic Modulation of Acute Myocardial Infarction The ECLA Glucose-Insulin-Potassium Pilot Trial , 1998 .
[34] Christopher H Schmid,et al. Summing up evidence: one answer is not always enough , 1998, The Lancet.
[35] J. Ioannidis,et al. Quantitative Synthesis in Systematic Reviews , 1997, Annals of Internal Medicine.
[36] C. Counsell,et al. Formulating Questions and Locating Primary Studies for Inclusion in Systematic Reviews , 1997, Annals of Internal Medicine.
[37] K. Beatt,et al. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials. , 1997, Circulation.
[38] R. Shemin,et al. Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. , 1997, The Journal of thoracic and cardiovascular surgery.
[39] J Herlitz,et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. , 1995, Journal of the American College of Cardiology.
[40] A. Maggioni,et al. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. , 1993, Journal of the American College of Cardiology.
[41] R. Newton,et al. Metabolic Control in Diabetic Subjects following Myocardial Infarction: Difficulties in Improving Blood Glucose Levels by Intravenous Insulin Infusion , 1991, Scottish medical journal.
[42] O. Frazier,et al. Improved cardiac function with glucose-insulin-potassium after aortocoronary bypass grafting. , 1989, The Annals of thoracic surgery.
[43] L. Opie,et al. Effects of preoperative glucose-insulin-potassium on myocardial glycogen levels and on complications of mitral valve replacement. , 1986, The Journal of thoracic and cardiovascular surgery.
[44] L. Smith,et al. Enhancement of left ventricular function by glucose-insulin-potassium infusion in acute myocardial infarction. , 1982, The American journal of cardiology.
[45] L. Smith,et al. Clinical effects of glucose-insulin-potassium on left ventricular function in acute myocardial infarction: results from a randomized clinical trial. , 1981, American heart journal.
[46] W. Rogers,et al. Prospective randomized trial of glucose-insulin-potassium in acute myocardial infarction , 1979 .
[47] R. Sautter,et al. Reduction of intraoperative myocardial infarction by means of exogenous anaerobic substrate enhancement: prospective randomized study. , 1978, The Annals of thoracic surgery.
[48] B. Singh,et al. Effects of glucose and glucose-insulin-potassium on haemodynamics and enzyme release after acute myocardial infarction. , 1977, British heart journal.
[49] R. Russell,et al. Metabolic consequences of glucose-insulin-potassium infusion in treatment of acute myocardial infarction. , 1976, The American journal of cardiology.
[50] Kallio,et al. Potassium, glucose, and insulin treatment for acute myocardial infarction. , 1969, Lancet.
[51] B. Pentecost,et al. Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. , 1968, Lancet.
[52] M. Malach. Polarizing solution in acute myocardial infarction. , 1967, The American journal of cardiology.
[53] R. Kernohan,et al. Potassium, glucose, and insulin in myocardial infarction. , 1967, Lancet.
[54] B. Mittra. Potassium, glucose, and insulin in treatment of myocardial infarction. , 1965, Lancet.
[55] I. Hirsch,et al. American College of Endocrinology position statement on inpatient diabetes and metabolic control. , 2004, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[56] L. Brodin,et al. Influence of glucose-insulin-potassium on left ventricular function during coronary artery bypass grafting. , 1993, Scandinavian journal of thoracic and cardiovascular surgery.
[57] T. Salerno,et al. Glucose substrate in myocardial protection. , 1980, The Journal of thoracic and cardiovascular surgery.
[58] J. Karnell,et al. Acute myocardial infarction treated by glucose-insulin-potassium (GIK) infusion. , 1966, Cardiologia.